Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-23T10:39:28.715Z Has data issue: false hasContentIssue false

Dextrose 10% in the Treatment of Out-of-Hospital Hypoglycemia

Published online by Cambridge University Press:  15 April 2014

Matthew V. Kiefer*
Affiliation:
Alameda County Medical Center, Highland Hospital, Department of Emergency Medicine, Oakland, California USA
H. Gene Hern
Affiliation:
Alameda County Medical Center, Highland Hospital, Department of Emergency Medicine, Oakland, California USA Contra Costa County Emergency Medical Services, Martinez, California USA
Harrison J. Alter
Affiliation:
Alameda County Medical Center, Highland Hospital, Department of Emergency Medicine, Oakland, California USA
Joseph B. Barger
Affiliation:
Contra Costa County Emergency Medical Services, Martinez, California USA
*
Correspondence: Matthew V. Kiefer, MD Alameda County Medical Center Highland Hospital Department of Emergency Medicine 1411 East 31st Street Oakland, CA 94602 USA E-mail [email protected]

Abstract

Introduction

Prehospital first responders historically have treated hypoglycemia in the field with an IV bolus of 50 mL of 50% dextrose solution (D50). The California Contra Costa County Emergency Medical Services (EMS) system recently adopted a protocol of IV 10% dextrose solution (D10), due to frequent shortages and relatively high cost of D50. The feasibility, safety, and efficacy of this approach are reported using the experience of this EMS system.

Methods

Over the course of 18 weeks, paramedics treated 239 hypoglycemic patients with D10 and recorded patient demographics and clinical outcomes. Of these, 203 patients were treated with 100 mL of D10 initially upon EMS arrival, and full data on response to treatment was available on 164 of the 203 patients. The 164 patients’ capillary glucose response to initial infusion of 100 mL of D10 was calculated and a linear regression line fit between elapsed time and difference between initial and repeat glucose values. Feasibility, safety, and the need for repeat glucose infusions were examined.

Results

The study cohort included 102 men and 62 women with a median age of 68 years. The median initial field blood glucose was 38 mg/dL, with a subsequent blood glucose median of 98 mg/dL. The median time to second glucose testing was eight minutes after beginning the 100 mL D10 infusion. Of 164 patients, 29 (18%) required an additional dose of IV D10 solution due to persistent or recurrent hypoglycemia, and one patient required a third dose. There were no reported adverse events or deaths related to D10 administration. Linear regression analysis of elapsed time and difference between initial and repeat glucose values showed near-zero correlation.

Conclusions

In addition to practical reasons of cost and availability, theoretical risks of using 50 mL of D50 in the out-of-hospital setting include extravasation injury, direct toxic effects of hypertonic dextrose, and potential neurotoxic effects of hyperglycemia. The results of one local EMS system over an 18-week period demonstrate the feasibility, safety, and efficacy of using 100 mL of D10 as an alternative. Additionally, the linear regression line of repeat glucose measurements suggests that there may be little or no short-term decay in blood glucose values after D10 administration.

KieferMV , HernHG , AlterHJ , BargerJB . Dextrose 10% in the Treatment of Out-of-Hospital Hypoglycemia. Prehosp Disaster Med. 2014;29(2):1-5.

Type
Brief Report
Copyright
Copyright © World Association for Disaster and Emergency Medicine 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Baker, L, Rattan, J, Bruno, A. Management of hyperglycemia in acute ischemic stroke. Curr Treat Options Neurol. 2011;13(6):616-628.Google Scholar
2. Browning, RG, Olson, DW, Stueven, HA, Mateer, JR. 50% dextrose: antidote or toxin? Ann Emerg Med. 1990;19(6):683-687.Google Scholar
3. Fahy, BG, Sheehy, AM, Coursin, DB. Glucose control in the intensive care unit. Crit Care Med. 2009;37(5):1769-1776.Google Scholar
4. Moore, C, Wollard, M. Dextrose 10% or 50% in the treatment of hypoglycemia out of hospital? A randomized controlled trial. Emerg Med J. 2005;22(7):512-515.CrossRefGoogle ScholarPubMed
5. Duning, T, Opiyo, N, English, M. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes Care. 2010;33(3):639-644.Google Scholar
6. Nakakimura, K, Fleischer, JE, Drummond, JC, et al. Glucose administration before cardiac arrest worsening neurologic outcome in cats. Anesthesiology. 1990;72(6):1005-1011.Google Scholar
7. Cain, E, Ackroyd-Stolarz, S, Alexiadis, P, Murray, D. Prehospital hypoglycemia: the safety of not transporting treated patients. Prehosp Emerg Care. 2003;7(4):458-465.Google Scholar
8. Collier, A, Steedman, DJ, Patrick, AW, et al. Comparison of intravenous glucagon and dextrose in treatment of severe hypoglycemia in an accident and emergency department. Diabetes Care. 1987;10(6):712-715.Google Scholar
9. Patrick, AW, Collier, A, Hepburn, DA, Steedman, DJ, Clarke, BF, Robertson, C. Comparison of intramuscular glucagon and intravenous dextrose in the treatment of hypoglycemic coma in an accident and emergency department. Arch Emerg Med. 1990;7(2):73-77.Google Scholar
10. Hoffman, JR, Schriger, DL, Votey, SR, Luo, JS. The empiric use of hypertonic dextrose in patients with altered mental status: a reappraisal. Ann Emerg Med. 1992;21(1):20-24.CrossRefGoogle ScholarPubMed
11. Hoffman, RS, Goldfrank, LR. The poisoned patient with altered consciousness. Controversies in the use of a ‘coma cocktail’. JAMA. 1995;274(7):562-569.CrossRefGoogle ScholarPubMed
12. Balantine, JR, Gaeta, TJ, Kessler, D, Bagiella, E, Lee, T. Effect of 50 milliliters of 50% dextrose in water administration on blood sugar of euglycemic volunteers. Acad Emerg Med. 1998;5(7):691-694.Google Scholar